Evolent Historical Income Statement
| EVH Stock | USD 12.93 0.33 2.49% |
Historical analysis of Evolent Health income statement accounts such as Gross Profit of 483.5 M or Other Operating Expenses of 2.1 B can show how well Evolent Health performed in making a profits. Evaluating Evolent Health income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Evolent Health's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Evolent Health latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Evolent Health is a good buy for the upcoming year.
Evolent |
About Evolent Income Statement Analysis
Evolent Health Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Evolent Health shareholders. The income statement also shows Evolent investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Evolent Health Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Evolent Health generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Evolent Health. It is also known as Evolent Health overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Cost Of Revenue
Cost of Revenue is found on Evolent Health income statement and represents the costs associated with goods and services Evolent Health provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Most accounts from Evolent Health's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Evolent Health current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolent Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.As of now, Evolent Health's Other Operating Expenses is increasing as compared to previous years. The Evolent Health's current Cost Of Revenue is estimated to increase to about 1.6 B, while Operating Income is projected to decrease to (74.8 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Total Revenue | 908.0M | 1.4B | 2.0B | 2.1B | Depreciation And Amortization | 60.0M | 90.3M | 123.4M | 129.6M |
Evolent Health income statement Correlations
Click cells to compare fundamentals
Evolent Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Evolent Health income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 54.9M | 60.8M | 60.0M | 90.3M | 123.4M | 129.6M | |
| Total Revenue | 846.4M | 1.0B | 908.0M | 1.4B | 2.0B | 2.1B | |
| Gross Profit | 333.3M | 321.1M | 250.4M | 316.6M | 460.5M | 483.5M | |
| Other Operating Expenses | 966.8M | 1.1B | 937.1M | 1.4B | 2.0B | 2.1B | |
| Operating Income | (120.4M) | (37.9M) | 30.2M | (59.8M) | (71.2M) | (74.8M) | |
| Ebit | (120.4M) | (302.2M) | (4.4M) | (46.5M) | (148.2M) | (155.6M) | |
| Ebitda | (65.5M) | (241.4M) | 55.7M | 43.7M | (24.8M) | (26.0M) | |
| Cost Of Revenue | 513.1M | 701.4M | 657.6M | 1.0B | 1.5B | 1.6B | |
| Total Operating Expenses | 453.7M | 372.0M | 279.5M | 336.5M | 531.7M | 558.3M | |
| Income Before Tax | (327.1M) | (337.8M) | (29.8M) | (62.1M) | (202.4M) | (192.3M) | |
| Total Other Income Expense Net | (206.7M) | (67.7M) | 12.6M | (65.7M) | (131.2M) | (124.6M) | |
| Net Income | (305.6M) | (334.2M) | (30.3M) | (18.7M) | (113.0M) | (107.4M) | |
| Income Tax Expense | (21.5M) | (3.6M) | 483K | (43.4M) | (89.4M) | (84.9M) | |
| Interest Expense | 14.5M | 28.3M | 25.4M | 15.6M | 54.2M | 56.9M | |
| Selling General Administrative | 392.8M | 310.6M | 219.5M | 245.7M | 358.1M | 236.7M | |
| Research Development | 19.8M | 15.1M | 15.5M | 27M | 26.7M | 16.2M | |
| Net Income From Continuing Ops | (302.0M) | (334.2M) | (30.3M) | (18.7M) | (113.0M) | (118.7M) | |
| Net Income Applicable To Common Shares | (302.0M) | (334.2M) | (37.6M) | (19.2M) | (17.2M) | (18.1M) | |
| Minority Interest | (1.5M) | (3.6M) | 2.0M | (822K) | (739.8K) | (702.8K) | |
| Tax Provision | (21.5M) | (3.6M) | 483K | (43.4M) | (89.4M) | (84.9M) | |
| Interest Income | 4.0M | 3.2M | 407K | 9.6M | 5.3M | 4.9M | |
| Non Operating Income Net Other | (5.5M) | (38.7M) | 13.6M | 6.0M | 5.4M | 5.1M | |
| Net Interest Income | (10.5M) | (25.2M) | (25.0M) | (14.2M) | (48.9M) | (46.5M) | |
| Reconciled Depreciation | 60.9M | 61.5M | 60.0M | 67.2M | 123.4M | 70.7M | |
| Extraordinary Items | 1.6M | 3.6M | (7.3M) | (463K) | (416.7K) | (437.5K) |
Currently Active Assets on Macroaxis
When determining whether Evolent Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evolent Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evolent Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evolent Health Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolent Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evolent Health. If investors know Evolent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evolent Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.92) | Revenue Per Share 21.554 | Quarterly Revenue Growth 0.216 | Return On Assets 0.0073 | Return On Equity (0.06) |
The market value of Evolent Health is measured differently than its book value, which is the value of Evolent that is recorded on the company's balance sheet. Investors also form their own opinion of Evolent Health's value that differs from its market value or its book value, called intrinsic value, which is Evolent Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evolent Health's market value can be influenced by many factors that don't directly affect Evolent Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evolent Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evolent Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evolent Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.